Search research articles
Contact Us
Filters
Showing results (181-190 of 292) with videos related to
Page
of 30
Sort By:
Journal of Assisted Reproduction and Genetics
|
September 14, 2017
Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications
Nina Rogenhofer, Lara R M Nienaber, Lea C Amshoff, et al.
Leukemia Research
|
August 1, 1993
Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside
J Thaler, T Fluckinger, H Huber, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 10, 1991
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]
J Thaler, T Kühr, G Gastl, et al.
Seminars in Hematology
|
July 1, 1993
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group
J Thaler, G Gastl, T Fluckinger, et al.
British Journal of Haematology
|
May 1, 1993
Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration
J Thaler, K Grünewald, C Gattringer, et al.
Leukemia Research
|
January 1, 1989
Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin
J Thaler, H Denz, O Dietze, et al.
Geburtshilfe Und Frauenheilkunde
|
April 15, 2024
National and International Comparisons of Gynecological Research in Germany Based on a Bibliometric Analysis of Publications
Bertram Häussler, Barbara Schmalfeldt, Senta Häussler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 18, 2011
Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe
G Resch, R Schaberl-Moser, P Kier, et al.
Leukemia Research
|
October 31, 2001
CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma
W Eisterer, O Bechter, W Hilbe, et al.
Journal of Reproductive Immunology
|
February 13, 2002
A repertoire of cytokines in human seminal plasma
Masahiko Maegawa, Masaharu Kamada, Minoru Irahara, et al.
Page
of 30
Search research articles
Search
Showing results (181-190 of 292) with videos related to
Sort By:
Page
of 30
Journal of Assisted Reproduction and Genetics
|
September 14, 2017
Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications
Nina Rogenhofer, Lara R M Nienaber, Lea C Amshoff, et al.
Leukemia Research
|
August 1, 1993
Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside
J Thaler, T Fluckinger, H Huber, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 10, 1991
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]
J Thaler, T Kühr, G Gastl, et al.
Seminars in Hematology
|
July 1, 1993
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group
J Thaler, G Gastl, T Fluckinger, et al.
British Journal of Haematology
|
May 1, 1993
Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration
J Thaler, K Grünewald, C Gattringer, et al.
Leukemia Research
|
January 1, 1989
Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin
J Thaler, H Denz, O Dietze, et al.
Geburtshilfe Und Frauenheilkunde
|
April 15, 2024
National and International Comparisons of Gynecological Research in Germany Based on a Bibliometric Analysis of Publications
Bertram Häussler, Barbara Schmalfeldt, Senta Häussler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 18, 2011
Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe
G Resch, R Schaberl-Moser, P Kier, et al.
Leukemia Research
|
October 31, 2001
CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma
W Eisterer, O Bechter, W Hilbe, et al.
Journal of Reproductive Immunology
|
February 13, 2002
A repertoire of cytokines in human seminal plasma
Masahiko Maegawa, Masaharu Kamada, Minoru Irahara, et al.
Page
of 30